Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Summer;19(2):116-122.
doi: 10.31486/toj.18.0138.

Acute Hematogenous Osteomyelitis in Children

Affiliations
Review

Acute Hematogenous Osteomyelitis in Children

Nimmy Thakolkaran et al. Ochsner J. 2019 Summer.

Abstract

Background: The epidemiology of acute hematogenous osteomyelitis (AHO) in children has changed. Methods: We reviewed the current literature regarding the epidemiology, microbiology, pathogenesis, clinical presentation, diagnosis, and antimicrobial management of AHO in children. Results: Staphylococcus aureus is the most common microorganism causing pediatric AHO, followed by group A Streptococcus (GAS). AHO due to community-associated methicillin-resistant Staphylococcus aureus (MRSA) can cause severe and complicated disease. Pathogen isolation by culture is key for targeted antibiotic therapy. Polymerase chain reaction assay in tissue sample or joint fluid may enhance the yield of Kingella kingae. C-reactive protein is useful in diagnosis and monitoring the course of AHO. Magnetic resonance imaging is the preferred diagnostic imaging study for AHO. Clindamycin or vancomycin (for serious disease) is recommended for empiric therapy of suspected AHO due to MRSA depending on the geographic prevalence. Penicillinase-stable penicillins or first-generation cephalosporins are preferred antibiotics to treat methicillin-sensitive S aureus (MSSA) infection. Beta-lactam agents are the drugs of choice for treating AHO due to K kingae, GAS, or Streptococcus pneumoniae. For uncomplicated AHO due to MSSA, a short parenteral antibiotic course followed by oral therapy for a minimum total duration of 3-4 weeks is adequate. Complicated AHO due to MRSA may warrant prolonged therapy with surgical intervention. Conclusion: Given the evolution of pathogens, the variability in clinical presentations and course ranging from simple to complex disease, and response to treatment, the management of AHO continues to evolve and warrants an individualized, multidisciplinary approach.

Keywords: Anti-bacterial agents; methicillin-resistant staphylococcus aureus; osteomyelitis.

PubMed Disclaimer

Figures

Figure.
Figure.
Magnetic resonance imaging of right ankle shows distal fibular osteomyelitis with subperiosteal abscess.

References

    1. Peltola H, Pääkkönen M. Acute osteomyelitis in children. N Engl J Med. 2014. Jan 23;370(4):4:352-360. doi: 10.1056/NEJMra1213956. - DOI - PubMed
    1. Riise ØR, Kirkhus E, Handeland KS, et al. Childhood osteomyelitis-incidence and differentiation from other acute onset musculoskeletal features in a population-based study. BMC Pediatr. 2008. Oct 20;8:45. doi: 10.1186/1471-2431-8-45. - DOI - PMC - PubMed
    1. Krogstad P. Osteomyelitis. In: Cherry J, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 7th ed Philadelphia, PA: Elsevier Saunders; 2014:711-727.
    1. Iliadis AD, Ramachandran M. Paediatric bone and joint infections. EFORT Open Rev. 2017. Mar 13;2(1):7-12. doi: 10.1302/2058-5241.2.160027. - DOI - PMC - PubMed
    1. Hong DK, Gutierrez K. Osteomyelitis In: Long SS, Prober CG, Fischer M, eds. Principles and Practice of Pediatric Infectious Diseases. 5th ed Philadelphia, PA: Elsevier; 2018:480-486.

LinkOut - more resources